by Nina D’Abreo, MD | Aug 15, 2022
Not all breast cancers are created equal. Historically those patients with hormone-driven breast cancer had better outcomes compared to those with HER2+ breast cancer. Human epidermal growth factor receptor 2 (HER2)/Neu is a kinase protein involved in normal cell...
by Nina D’Abreo, MD | Sep 18, 2018
At our hospital, we get a lot of questions about immunotherapy treatments for breast cancer. Immunotherapy is one of latest, most promising lines of research in breast cancer, part of a growing breed of biologic therapies. Immunotherapy is often mentioned in the same...
by Nina D’Abreo, MD | Jan 29, 2018
If you or a loved one has increased risk factors for breast cancer, developing a risk reduction plan is an important conversation to have with your doctor. At our hospital, we always recommend tackling obesity and alcohol usage first, but for those at high risk,...
